title: Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7.
abstract: A variety of chemokines has been shown to recruit human bone marrow-derived mesenchymal stem cells (MSC) and may be potential candidates for chemokine-based tissue regeneration approaches. The aim of our study was to determine whether the chemokine CXCL7 stimulates migration of human bone marrow-derived MSC and to analyze the effect of CXCL7 on the recruitment of MSC on the broad molecular level. Chemotaxis assays documented that high doses of CXCL7 significantly recruited MSC. Gene expression profiling using oligonucleotide microarrays showed that MSC treated with CXCL7 differentially expressed genes related to cell migration, cell adhesion and extracellular matrix remodeling. Pathway analysis showed that CXCL7 induced the expression of all chemokines binding the interleukin (IL) receptors A and B, CXCR1 and CXCR2, as well as the IL6 signal transducer (gp130) and its ligands IL6 and leukemia inhibitory factor (LIF). Induction of differentially expressed chemokines CXCL1-3, CXCL5, and CXCL6 as well as LIF and gp130 in MSC by CXCL7 was verified by real-time polymerase chain reaction. Immunoassay of cell culture supernatants confirmed elevated levels of the interleukins 6 and 8 in MSC upon treatment with CXCL7. Chemotaxis assays showed that interleukin 6 did not recruit MSC. In conclusion, CXCL7 significantly stimulates the migration of human MSC in vitro. Pathway analysis suggests that recruitment of human MSC by CXCL7 is supported by the induction of ligands of the interleukin 8 receptors, synergistically activating the respective signaling pathways.
authors.affiliation: TransTissue Technologies GmbH, Tucholskystrasse 2, 10117 Berlin, Germany.
authors.forename: Gregor
authors.initials: G
authors.lastname: Kalwitz
authors.forename: Michaela
authors.initials: M
authors.lastname: Endres
authors.forename: Katja
authors.initials: K
authors.lastname: Neumann
authors.forename: Karl
authors.initials: K
authors.lastname: Skriner
authors.forename: Jochen
authors.initials: J
authors.lastname: Ringe
authors.forename: Orhan
authors.initials: O
authors.lastname: Sezer
authors.forename: Michael
authors.initials: M
authors.lastname: Sittinger
authors.forename: Thomas
authors.initials: T
authors.lastname: Häupl
authors.forename: Christian
authors.initials: C
authors.lastname: Kaps
mesh_terms: D000328:Adult; D001853:Bone Marrow / Q000276:immunology; D002448:Cell Adhesion; D002465:Cell Movement; D002478:Cells, Cultured; D050822:Cytokine Receptor gp130 / Q000235:genetics / Q000378:metabolism; D020869:Gene Expression Profiling; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism*; D016209:Interleukin-8 / Q000378:metabolism*; D053605:Leukemia Inhibitory Factor / Q000235:genetics / Q000378:metabolism; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000276:immunology / Q000378:metabolism*; D023063:Receptors, Interleukin-8B / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000276:immunology; D001620:beta-Thromboglobulin / Q000276:immunology / Q000378:metabolism*
chemical_list: D015850:Interleukin-6; D016209:Interleukin-8; C507837:LIF protein, human; D053605:Leukemia Inhibitory Factor; C061615:PPBP protein, human; D023063:Receptors, Interleukin-8B; D001620:beta-Thromboglobulin; D050822:Cytokine Receptor gp130